Publicaciones en las que colabora con Manuel Naves Díaz (17)

2024

  1. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. Dietary phosphate restriction prevents the appearance of sarcopenia signs in old mice

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 14, Núm. 2, pp. 1060-1074

  2. Effects of a Losartan-Antioxidant Hybrid (GGN1231) on Vascular and Cardiac Health in an Experimental Model of Chronic Renal Failure

    Nutrients, Vol. 15, Núm. 8

  3. Redox Metabolism and Vascular Calcification in Chronic Kidney Disease

    Biomolecules, Vol. 13, Núm. 9

  4. Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment

    Nutrients, Vol. 15, Núm. 6

2022

  1. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  2. Vitamin D Treatment Prevents Uremia-Induced Reductions in Aortic microRNA-145 Attenuating Osteogenic Differentiation despite Hyperphosphatemia

    Nutrients, Vol. 14, Núm. 13

2021

  1. Contribution of phosphorus and PTH to the development of cardiac hypertrophy and fibrosis in an experimental model of chronic renal failure

    Nefrologia, Vol. 41, Núm. 6, pp. 640-651

  2. Effects of calcitriol and paricalcitol on renal fibrosis in CKD

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 36, Núm. 5, pp. 793-803

  3. Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders

    Calcified Tissue International, Vol. 108, Núm. 4, pp. 439-451

  4. Uraemic toxins impair skeletal muscle regeneration by inhibiting myoblast proliferation, reducing myogenic differentiation, and promoting muscular fibrosis

    Scientific Reports, Vol. 11, Núm. 1

2017

  1. Effects of the catalase antioxidant enzyme in vascular calcification and bone demineralization

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 9, Núm. 1, pp. 13-19

  2. Hyperphosphatemia induces senescence in human endothelial cells by increasing endothelin-1 production

    Aging Cell, Vol. 16, Núm. 6, pp. 1300-1312

2016

  1. Lamin A is involved in the development of vascular calcification induced by chronic kidney failure and phosphorus load

    Bone, Vol. 84, pp. 160-168

  2. MicroRNAs 29b, 133b, and 211 regulate vascular smooth muscle calcification mediated by high phosphorus

    Journal of the American Society of Nephrology, Vol. 27, Núm. 3, pp. 824-834

2015

  1. Hyperphosphatemia induces cellular senescence in human aorta smooth muscle cells through integrin linked kinase (ILK) up-regulation

    Mechanisms of Ageing and Development, Vol. 152, pp. 43-55

2010

  1. High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression

    Bone, Vol. 46, Núm. 1, pp. 121-128